Delivery Order SPE2DE24DA017-SPE2D625F213C

Award Date 10/29/24
Potential Completion Date 11/1/24
Potential Value $3.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products, was issued by the Defense Logistics Agency's Medical Supply Chain. The $14,308.80 fixed-price delivery order is for the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device for platelet-rich plasma procedures. The contract has an ultimate completion date of December 13, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has been awarded this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,577.20 fixed-price delivery order is for the supply of Arthrex's ANGEL PRP (Platelet-Rich Plasma) Kits, which are used in orthopedic procedures. This contract is not designated as a set-aside. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant single-award Indefinite...
This federal contract award, valued at $1,788.60, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a for-profit Subchapter S Corporation headquartered in Naples, Florida. The contract is a Delivery Order for the ARTHREX ANGEL PRP KIT (US TRAY), a product used in orthopedic procedures. Arthrex is a global leader in minimally invasive orthopedic products and procedures, and this award demonstrates the company's ability to efficiently support...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, headquartered in Naples, Florida. The contract, valued at $7,154.40, is a Delivery Order for the ARTHREX ANGEL PRP KIT (US TRAY) product. The contract has a fixed price with economic price adjustment pricing type and a completion date of November 1, 2024. Arthrex is a for-profit Subchapter S Corporation that...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, is for the delivery of ARTHREX ANGEL PRP (Platelet-Rich Plasma) Kits to the Medical Supply Chain of the Defense Logistics Agency (DLA). The $3,577.20 fixed-price with economic price adjustment contract has a completion date of November 25, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has consistently been awarded delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain, a defense agency, to Arthrex Inc., a for-profit Subchapter S Corporation headquartered in Naples, Florida. The contract, valued at $9,300.72, is a Delivery Order contract with a fixed price and economic price adjustment pricing type. The contract is for the provision of the ARTHREX ANGEL PRP (Platelet-Rich Plasma) KIT (US TRAY) medical product, with an ultimate completion date of October 21,...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,788.60, is for the delivery of Arthrex's ANGEL PRP (Platelet-Rich Plasma) KIT (US TRAY) and has a completion date of October 24, 2024. This delivery order contract is a fixed-price with economic price adjustment arrangement and is not designated as a set-aside contract. Arthrex, a...
This federal contract award was made by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $5,365.80 fixed-price with economic price adjustment delivery order is for the Arthrex Angel PRP (Platelet-Rich Plasma) Kit, a specialized medical device used in orthopedic procedures. The contract has a period of performance through December 4, 2024 and was awarded on November 29, 2024. Arthrex, a...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,219.48 fixed-price delivery order is for the ARTHREX ANGEL PRP KIT (US TRAY) and has an ultimate completion date of October 25, 2024. Arthrex, a for-profit Subchapter S Corporation, has been awarded this contract to provide specialized orthopedic solutions to government healthcare systems, particularly...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $14,308.80 Delivery Order (SPE2D625F00U8) is for the procurement of the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical product used in orthopedic procedures. This contract is not designated as a set-aside and is priced on a Fixed Price with Economic Price Adjustment basis. The...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F213C
    Delivery Order

This federal contract award was issued by the Department of Defense's (DoD) Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,577.20 fixed-price delivery order is for the supply of ARTHREX ANGEL PRP (Platelet-Rich Plasma) KIT (US TRAY) and has an ultimate completion date of November 1, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. This particular delivery order is not designated as a set-aside contract, indicating Arthrex's strong competitive position in the open federal market. The contract award demonstrates Arthrex's ability to efficiently support government healthcare systems, such as the Department of Veterans Affairs (VA) and the DoD, with specialized orthopedic solutions tailored to meet the diverse medical needs of veterans and military personnel.

Generated 1/28/25, 12:13 PM